Medical Information
|
Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
  • Rare Renal Disorders Home
  •  Icon
    Product
    PH1 Product Information
    Product Resources Library
    Medical Information
    |
    Non-US Health Care Professionals
  • Contact Your Representative
  •  Icon
    Disease Education
    What Is PH1?
    Identifying & Diagnosing
    Medical Information
    |
    Non-US Health Care Professionals
  •  Icon
    Product Education
    Patient Education Materials
     Icon
    Additional Resources
    Professional & Patient Organizations
    Medical Information
    |
    Non-US Health Care Professionals
Rare Renal Disorders
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg logo
  • Understanding PH1
  • About Rivfloza®
  • Efficacy and Safety
  • Dosing and Administration
  • Start Your Patients
  • Resources
Prescribing Information | Important Safety Information

Explore Therapeutic Areas

Diabetes Icon
Diabetes
Our broad treatment portfolio supports individualized patient care.
Obesity Icon
Obesity
Our treatments are part of a comprehensive approach to weight-loss management.
Growth-Related Disorders Icon
Growth-Related Disorders
Our products help children with a range of growth-related disorders and adults with growth hormone deficiency.
Rare Bleeding Disorders Icon
Rare Bleeding Disorders
Our commitment to patients with hemophilia and rare bleeding disorders is reflected in our broad therapy portfolio.
Rare Renal Disorders Icon
Rare Renal Disorders
Our treatment helps patients with the rare genetic disorder primary hyperoxaluria type 1 (PH1).
Medical Information
|
Non-US Health Care Professionals
  • Rare Renal Disorders Home
  • Contact Your Representative
Account Settings
Sign Out
Sign In | Create Account
Update your account
Medical Information
|
Non-US Health Care Professionals

Explore the Hub

Products
Samples
Patient Savings
Contact

Explore Therapeutic Areas

Diabetes
Diabetes
Obesity
Obesity
Growth-Related Disorders
Growth-Related Disorders
Rare Bleeding Disorders
Rare Bleeding Disorders
Rare Renal Disorders
Rare Renal Disorders
Claim your personalized professional hub
What can novoMEDLINK™ do for you? With your account you can discover professional news, order samples, get supply updates, browse patient support materials, and much more.
Personalize your novoMEDLINK™ experience
Ready to further optimize your content recommendations and resource suggestions? Head to your account page to edit your settings.
Account Settings
Sign Out
Sign In | Create Account
Update your account
  • Products
    Samples
    Patient Savings
    Contact
    Diabetes
    Diabetes
    Obesity
    Obesity
    Growth-Related Disorders
    Growth-Related Disorders
    Rare Bleeding Disorders
    Rare Bleeding Disorders
    Rare Renal Disorders
    Rare Renal Disorders
Claim your personalized
professional hub
Personalize your novoMEDLINK™ experience
Account Settings
Sign Out
Sign In | Create Account
Update your account
Medical Information
|
Non-US Health Care Professionals
  • Rare Renal Disorders Home
  •  Icon
    Product
    PH1 Product Information
    Product Resources Library
  • Contact Your Representative
  •  Icon
    Disease Education
    What Is PH1?
    Identifying & Diagnosing
  •  Icon
    Product Education
    Patient Education Materials
     Icon
    Additional Resources
    Professional & Patient Organizations
Medical Information
|
Non-US Health Care Professionals

Explore Current Therapy Area

Rare Renal Disorders Home
Product
PH1 Product Information
Product Resources Library
Disease Education
What Is PH1?
Identifying & Diagnosing
Product Education
Patient Education Materials
Additional Resources
Professional & Patient Organizations
Diabetes
Diabetes
Obesity
Obesity
Growth-Related Disorders
Growth-Related Disorders
Rare Bleeding Disorders
Rare Bleeding Disorders
Rare Renal Disorders
Rare Renal Disorders
Medical Information
|
Non-US Health Care Professionals
Claim your personalized professional hub
What can novoMEDLINK™ do for you? With your account you can discover professional news, order samples, get supply updates, browse patient support materials, and much more.
Personalize your novoMEDLINK™ experience
Ready to further optimize your content recommendations and resource suggestions? Head to your account page to edit your settings.
Account Settings
Sign Out
Sign In | Create Account
Update your account

Explore Current Therapy Area

  • Rare Renal Disorders Home
  •  Icon
    Product
    PH1 Product Information
    Product Resources Library
  • Contact Your Representative
  •  Icon
    Disease Education
    What Is PH1?
    Identifying & Diagnosing
  •  Icon
    Product Education
    Patient Education Materials
     Icon
    Additional Resources
    Professional & Patient Organizations
  • Diabetes
    Diabetes
    Obesity
    Obesity
    Growth-Related Disorders
    Growth-Related Disorders
    Rare Bleeding Disorders
    Rare Bleeding Disorders
    Rare Renal Disorders
    Rare Renal Disorders

Claim your personalized
professional hub

Personalize your novoMEDLINK™ experience

Account Settings
Sign Out
Sign In | Create Account
Update your account
Medical Information
|
Non-US Health Care Professionals
  • Understanding PH1
  • About Rivfloza®
  • Efficacy and Safety
  • Dosing and Administration
  • Start Your Patients
  • Resources
Prescribing Information | Important Safety Information
Medical Information
|
Non-US Health Care Professionals
Prescribing Information  |  Important Safety Information

For adults and children aged 2 years and older with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Rivfloza® (nedosiran) injection support and resources created with you and your patients in mind

Novo Nordisk is committed to supporting you and your patients with primary hyperoxaluria type 1 (PH1) throughout the treatment journey. Explore our library of resources below.

Rivfloza® (nedosiran) injection support and resources created with you and your patients in mind

Novo Nordisk is committed to supporting you and your patients with primary hyperoxaluria type 1 (PH1) throughout the treatment journey. Explore our library of resources below.

Resources designed for your office

Here you will find several educational resources that outline treatment efficacy, safety, dosing, and more:

Rivfloza® Prescribing Information brochure
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Rivfloza® Prescribing Information brochure
Explore Prescribing Information about Rivfloza®.
Download
Prescribing Information | Important Safety Information
HCP Dosing Guide
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
HCP Dosing Guide
Learn about dosing for adult and pediatric patients.
Download
Prescribing Information | Important Safety Information
NovoCare® Start Form
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
NovoCare® Start Form
Ready to prescribe Rivfloza®? Start here.
Download
Prescribing Information | Important Safety Information
Prescribing Information | Important Safety Information | Instructions for Use
MOA video
(3:34)
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
MOA video
Gain a better understanding of how Rivfloza® works with this animated video.
Watch video
Prescribing Information | Important Safety Information
Rivfloza® Brochure
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Rivfloza® Brochure
Explore key points about Rivfloza®.
Download
Prescribing Information | Important Safety Information

Educational materials for patients and caregivers

Discover supportive resources dedicated to patient and caregiver education:

Patient Brochure
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Patient Brochure
Share this with your patients as a helpful reference on Rivfloza®.
Download
Prescribing Information | Important Safety Information
NovoCare® brochure
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
NovoCare® brochure
A printable resource to help patients starting therapy.
Download
Prescribing Information | Important Safety Information
Prescribing Information | Important Safety Information | Instructions for Use
Administration video – vial
(8:48)
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Administration video – vial
See how to administer Rivfloza® using the single-dose vial.
Watch video
Prescribing Information | Important Safety Information
Prescribing Information | Important Safety Information | Instructions for Use
Administration video – prefilled syringe
(6:38)
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Administration video – prefilled syringe
See how to administer Rivfloza® using the prefilled syringe.
Watch video
Prescribing Information | Important Safety Information
Patient Dosing and Administration Guide
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Patient Dosing and Administration Guide
Guide to help patients properly administer Rivfloza®.
Download
Prescribing Information | Important Safety Information

Discover community and education for your patients

Oxalosis & Hyperoxaluria Foundation logo

OHF: Oxalosis & Hyperoxaluria Foundation

OHF brings people together to advocate and advance toward a cure.

Visit site
National Organization for Rare Disorders logo

NORD: National Organization for Rare Disorders

NORD helps people battling rare disease feel seen, heard, supported, and connected.

Visit site
American Kidney Fund logo

AKF: American Kidney Fund

AKF provides life-saving financial assistance and life-changing educational resources for people impacted by kidney disease.

Visit site
National Kidney Foundation logo

NKF: National Kidney Foundation

NKF provides education, resources, support, and advocacy for people living with kidney disease.

Visit site
Bell icon

Stay updated by creating your novoMEDLINKTM account today

Sign up

Person with headset icon

Have questions about Rivfloza®? Reach out to our team of representatives

Connect with a representative

Show More Show Less

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Show More Show Less
Show More Show Less

Indication and Usage

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

For Health Care Professionals
  • Rare Renal Disorders Home
  • Product Information
    Product
    • PH1 Product Information
      Product Resources Library
  • Contact Your Representative
  • Professional Education
    Disease Education
    • What Is PH1?
      Identifying & Diagnosing
  • Patient Support
    Product Education
    • Patient Education Materials
    Additional Resources
    • Professional & Patient Organizations

PHYOX™ is a trademark and Rivfloza® is a registered trademark of Novo Nordisk Health Care AG.
novoMEDLINK™ is a trademark and NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Terms of Use | Privacy Notice | Consumer Health Privacy Notice | Cookie Notice | Privacy Request | Contact Us |
novonordisk-us.com    
© 2025 Novo Nordisk All rights reserved. US25RVZA00017 May 2025

What can we help you do today?

Quick links

 

 

Medical Information     |     Non-US Health Care Professionals